2-amino-7-hydroxytetraline ethers
    2.
    发明授权
    2-amino-7-hydroxytetraline ethers 失效
    2-氨基-7-羟基四氢化萘

    公开(公告)号:US5202466A

    公开(公告)日:1993-04-13

    申请号:US922486

    申请日:1992-07-31

    IPC分类号: C07C229/00

    CPC分类号: C07C229/00

    摘要: 2-amino-7-hydroxytetraline ethers of formula ##STR1## wherein R' represents methyl substituted by a carboxy group or lower carbalkoxy group or a salt thereof; a process for their preparation starting from the 2-amino-7-hydroxytetraline, N-protection, O-alkylation and N-deprotection; N-protected intermediates; and use of the compounds I for the preparation of the corresponding phenylethanolaminotetralines.

    摘要翻译: 其中R'表示被羧基或低级烷氧羰基取代的甲基或其盐的2-氨基-7-羟基四氢化萘, 从2-氨基-7-羟基四氢化萘,N-保护,O-烷基化和N-去保护开始制备其制备方法。 N-保护的中间体; 以及使用化合物I制备相应的苯基乙醇胺三酰四氢呋喃。

    2-amino-7-hydroxytetraline ethers
    3.
    发明授权
    2-amino-7-hydroxytetraline ethers 失效
    2-氨基-7-羟基四氢化萘

    公开(公告)号:US5159103A

    公开(公告)日:1992-10-27

    申请号:US825841

    申请日:1992-01-28

    CPC分类号: C07C217/94 C07C2102/10

    摘要: 2-amino-7-hydroxytetraline ethers of formula ##STR1## wherein R' represents methyl substituted by a carboxy group or lower carbalkoxy group or a salt thereof; a process for their preparation starting from the 2-amino-7-hydroxytetraline, N-protection, O-alkylation and N-deprotection; N-protected intermediates; and use of the compounds I for the preparation of the corresponding phenylethanolaminotetralines.

    摘要翻译: 其中R'表示被羧基或低级烷氧羰基取代的甲基或其盐的2-氨基-7-羟基四氢化萘, 从2-氨基-7-羟基四氢化萘,N-保护,O-烷基化和N-去保护开始制备其制备方法。 N-保护的中间体; 以及使用化合物I制备相应的苯基乙醇胺三酰四氢呋喃。

    Process for the preparation of phenylethanolaminotetralins
    6.
    发明授权
    Process for the preparation of phenylethanolaminotetralins 失效
    制备苯乙醇氨基三苯乙烯的方法

    公开(公告)号:US5235103A

    公开(公告)日:1993-08-10

    申请号:US990762

    申请日:1992-12-15

    IPC分类号: C07C233/12

    CPC分类号: C07C233/12

    摘要: A process for the preparation of phenylethanolaminotetralins of formula ##STR1## wherein X is hydrogen, a halogen, a trifluoromethyl or a lower alkyl group and R.sup.o is hydrogen or a methyl group substituted by a carboxy or a lower carbalkoxy group, which comprises treating a mandelic acid with a 2-amino-7-hydroxytetralin, optionally alkylating with a lower alkyl haloacetate and reducing the amido group of the mandelamide into a methyleneamino group. The mandelamides intermediates are novel.

    摘要翻译: 一种制备式IMAMA的苯基乙醇氨基十氢化萘的方法,其中X是氢,卤素,三氟甲基或低级烷基,Ro是氢或被羧基或低级烷氧基取代的甲基,其包括处理扁桃酸 酸与2-氨基-7-羟基四氢萘,任选地与卤代低级烷基酯烷基化,并将扁桃酰胺的酰胺基还原成亚甲基氨基。 扁桃酰胺中间体是新颖的。

    Process for the preparation of phenylethanolaminotetralins
    7.
    发明授权
    Process for the preparation of phenylethanolaminotetralins 失效
    制备苯乙醇氨基三苯乙烯的方法

    公开(公告)号:US5198586A

    公开(公告)日:1993-03-30

    申请号:US603247

    申请日:1990-10-25

    IPC分类号: C07C233/12

    CPC分类号: C07C233/12

    摘要: A process for the preparation of phenylethanolaminotetralins of formula ##STR1## wherein X is hydrogen, a halogen, a trifluoromethyl or a lower alkyl group and R.degree. is hydrogen or a methyl group substituted by a carboxy or a lower carbalkoxy group, which comprises treating a mandelic acid with a 2-amino-7-hydroxytetralin, optionally alkylating with a lower alkyl haloacetate and reducing the amido group of the mandelamide into a methyleneamino group. The mandelamides intermediates are novel.

    摘要翻译: 一种制备式IMAMA的苯乙醇氨基十氢化萘的方法,其中X为氢,卤素,三氟甲基或低级烷基,R为氢或被羧基或低级烷氧基取代的甲基,其包括处理 扁桃酸与2-氨基-7-羟基四氢萘基,任选地与卤代低级烷基酯烷基化并将扁桃酰胺的酰胺基还原成亚甲基氨基。 扁桃酰胺中间体是新颖的。

    2-amino-7-hydroxytetralin carboxylalkyl ethers
    10.
    发明授权
    2-amino-7-hydroxytetralin carboxylalkyl ethers 失效
    2-氨基-7-羟基四氢萘基羧基烷基醚

    公开(公告)号:US5312961A

    公开(公告)日:1994-05-17

    申请号:US905483

    申请日:1992-06-29

    摘要: The invention relates to 2-amino-7-hydroxytetralin carboxyalkyl ethers of formula ##STR1## wherein Alk represents a straight or branched (C.sub.3 -C.sub.5)alkylene group, and R is hydrogen or (C.sub.1 -C.sub.4)alkyl, useful as starting materials in the synthesis of 7-substituted phenylethanolaminotetralins of formula (XII) ##STR2## wherein X represents hydrogen, halogen, (C.sub.1 -C.sub.4)alkyl, or trifluoromethyl which are useful as spasmolytics and anti-glaucoma agents.The new 7-substituted phenylethanolaminotetralins (XII) as well as the intermediates in the preparation of the compounds (I), the N-protected 2-amino-7-hydroxytetralin carboxyalkyl ethers, are also claimed.

    摘要翻译: 本发明涉及式(I)的2-氨基-7-羟基四氢萘羧酸烷基醚,其中Alk表示直链或支链(C3-C5)亚烷基,R是氢或(C1-C4)烷基,可用作 合成式(XII)的7-取代苯乙醇氨基十氢化萘(XII)的原料,其中X代表氢,卤素,(C1-C4)烷基或三氟甲基,其可用作解聚物和抗青光眼剂。 还要求保护新的7-取代苯乙醇氨基十氢化萘(XII)以及化合物(I),N-保护的2-氨基-7-羟基四氢萘烷羧基烷基醚的制备中的中间体。